• No results found

[PDF] Top 20 Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro.

Has 10000 "Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro." found on our website. Below are the top 20 most common "Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro.".

Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro.

Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro.

... 225 Downloaded from http://jvi.asm.org/ on November 10, 2019 by guest The evolution of an 851-bp segment of the human immunodeficiency virus type 1 HIV-1 genome encoding the nef open rea[r] ... See full document

7

Genetic drift can dominate short-term human immunodeficiency virus type 1 nef quasispecies evolution in vivo.

Genetic drift can dominate short-term human immunodeficiency virus type 1 nef quasispecies evolution in vivo.

... of virus-pulsed antigen-presenting dendritic cells and CD4 T lymphocytes in vitro (75, 83) as well as by vaccination- induced T-cell activation in seropositive patients (27, 56, ...the evolution of ... See full document

8

Viral Phenotypes and Antibody Responses in Long-Term Survivors Infected with Attenuated Human Immunodeficiency Virus Type 1 Containing Deletions in the nef and Long Terminal Repeat Regions

Viral Phenotypes and Antibody Responses in Long-Term Survivors Infected with Attenuated Human Immunodeficiency Virus Type 1 Containing Deletions in the nef and Long Terminal Repeat Regions

... isolated virus replicated poorly, similar to virus isolated from C64, who maintained a consistently undetectable viral ...independent evolution of each virus after infection of each individual ... See full document

11

Targeted Derepression of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat by Pyrrole-Imidazole Polyamides

Targeted Derepression of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat by Pyrrole-Imidazole Polyamides

... in vitro. (A) Sequences of the RCS (gray)- and LSF-binding motifs (underlined), sequences targeted by polyamides 1, 2, 3 and 4 (boxed), and oligonucleotide probes (thick lines below) ... See full document

6

Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat.

Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat.

... control human immunodeficiency virus type 1 (HIV-1) gene expression reside in the long terminal repeat ...In vitro and in vivo studies have ... See full document

5

Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection.

Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection.

... Human immunodeficiency virus type 1 (HIV-1) infection leads to generalized dysfunction of the immune system and development of AIDS in the majority of HIV-1-infected indi- ... See full document

6

Grossly Defective nef Gene Sequences in a Human Immunodeficiency Virus Type 1-Seropositive Long-Term Nonprogressor

Grossly Defective nef Gene Sequences in a Human Immunodeficiency Virus Type 1-Seropositive Long-Term Nonprogressor

... as long-term nonprogres- sive human immunodeficiency virus type 1 (HIV-1) infection, a condition that affects only a small percentage of the total HIV-1-infected ... See full document

12

Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.

Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.

... ; 1 to 25 of E1A for in vivo association is the 300-kDa cellular protein p300 (for a review, see reference ...simian virus 40 promoter in transient expression analysis ...D 4-25 is defective ... See full document

5

Longitudinal Analysis of Human Immunodeficiency Virus Type 1 nef/Long Terminal Repeat Sequences in a Cohort of Long-Term Survivors Infected from a Single Source

Longitudinal Analysis of Human Immunodeficiency Virus Type 1 nef/Long Terminal Repeat Sequences in a Cohort of Long-Term Survivors Infected from a Single Source

... 25 years. The intersubject evolution of nef/ LTR sequence loss appears convergent, tending toward reten- tion of only those sequence elements that are absolutely re- quired for HIV-1 ... See full document

6

Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1.

Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1.

... a human binding site for b-HLH proteins, contained in a human origin of DNA replication (6, 26), acts as a downregulator of transcription when cloned upstream of the enhancer region of the LTR, therefore ... See full document

11

Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.

Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.

... LTR transcriptional activity obtained by using NXS mutants in Jurkat cells Spl, TATA, LBP-1, UBP-2 a NRE, Negative regulatory element; IL-2, interleukin-2; IL-2Ra, interleukin-2 receptor[r] ... See full document

9

Evolution of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat Promoter by Conversion of an NF-κB Enhancer Element into a GABP Binding Site

Evolution of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat Promoter by Conversion of an NF-κB Enhancer Element into a GABP Binding Site

... the long-term infection ...the virus could amplify the residual Tat activity encoded by the mutant Tyr26Ala ...revertant virus, and this putative Tat rever- tant protein is currently being ... See full document

10

5′-Long Terminal Repeat-Selective CpG Methylation of Latent Human T-Cell Leukemia Virus Type 1 Provirus In Vitro and In Vivo

5′-Long Terminal Repeat-Selective CpG Methylation of Latent Human T-Cell Leukemia Virus Type 1 Provirus In Vitro and In Vivo

... DNA sequences of the integrated provirus by using the inverse PCR technique ...have 1 copy of integrated provirus, whereas MT-1 cells have 10 copies, based on the Southern blot ...MT-1. ... See full document

9

Identification of c fos responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type 1

Identification of c fos responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type 1

... proviral long terminal repeat ...leader sequences downstream of the viral transactivator responsive (TAR) ...using human colon epithelial cell lines, demonstrate that the downstream ... See full document

14

Association of Nef with the Human Immunodeficiency Virus Type 1 Core

Association of Nef with the Human Immunodeficiency Virus Type 1 Core

... which Nef may enhance HIV-1 infec- tivity is by altering the intracellular transport of the incoming viral ribonucleoprotein ...Because Nef interacts with components of the endocytic machinery to ... See full document

7

The Human Factors YY1 and LSF Repress the Human Immunodeficiency Virus Type 1 Long Terminal Repeat via Recruitment of Histone Deacetylase 1

The Human Factors YY1 and LSF Repress the Human Immunodeficiency Virus Type 1 Long Terminal Repeat via Recruitment of Histone Deacetylase 1

... YY1 is known to interact with a number of cellular factors via a Gly/Ala-rich region within residues 154 to 199 (2). LSF, however, interacts with the zinc finger domain of YY1. The Gly/Ala domain was present on all ... See full document

10

Sequences outside of the long terminal repeat determine the lymphomogenic potential of Rous-associated virus type 1.

Sequences outside of the long terminal repeat determine the lymphomogenic potential of Rous-associated virus type 1.

... For example, helper viruses isolated from stocks of the Bryan high-titer strain of Rous sarcoma virus Rous-associated virus types 1 and 2 [RAV-1 and RAV-2, respectively] induce high inci[r] ... See full document

8

A fourth Sp1 site in the human immunodeficiency virus type 1 long terminal repeat is essential for negative-sense transcription.

A fourth Sp1 site in the human immunodeficiency virus type 1 long terminal repeat is essential for negative-sense transcription.

... the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (HIV-1 Sp1 IV), localized to HXB2 nucleotides 2 433 to 2 ...HXB2-derived ... See full document

8

Identification of transactivation-response sequences in the long terminal repeat of bovine immunodeficiency-like virus.

Identification of transactivation-response sequences in the long terminal repeat of bovine immunodeficiency-like virus.

... Deletion analysis of the long terminal repeat indicated that sequences containing the proximal stem-loop structure located between +4 and +31 are required for virus-specific transactivat[r] ... See full document

5

The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity.

The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity.

... 4919-4924 0022-538X/89/114919-06$02.00/0 Copyright C 1989, American Society for Microbiology The NF-KB Binding Sites in the Human Immunodeficiency Virus Type 1 Long Terminal Repeat Are N[r] ... See full document

6

Show all 10000 documents...